Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Concert Pharmaceuticals, Inc.
Work at Concert Pharmaceuticals, Inc.?
Add yourself to this profile
2879
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.
Edit Profile
concertpharma.com
Health Care
>
Medical
>
Pharmaceuticals
B2b
Founded in
2006
Raised
$125.5M
More info
Elsewhere
Contributors to this profile
Companies in the same industry
Transaction Data Sys
POZEN
Mark Montgomery
CogniFit
Pearl Therapeutics
SHINE Medical Technologies
Aerie Pharmaceuticals
HealthCare Royalty Partners
Avila Therapeutics
SkinMedica
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
Post-IPO debt
$30,000,000
Hercules Capital, Inc.
Venture capital (Series C)
$37,000,000
Adage Capital Management
,
Flagship Ventures
,
Greylock Partners
,
+9
Employees
Team size
50+
Locations
HQ
United States
Headquarters
$30,000,000
Post-IPO debt
businesswire
,
PE Hub
Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital
$48,500,000
Venture capital (Series B)
Added by
via
PE Hub
Concert Pharma Raises $48.5 Million
Transaction Data Sys
Mark Montgomery
CogniFit
Pearl Therapeutics
SHINE Medical Technologies
Aerie Pharmaceuticals
SkinMedica